Evidence map›Paper›PMID 30288478›Full record

ArticleHepatology communications2018

CEACAM1 Is Associated With the Suppression of Natural Killer Cell Function in Patients With Chronic Hepatitis C.

Takahiro Suda, Tomohide Tatsumi, Akira Nishio, Tadashi Kegasawa, Teppei Yoshioka, Ryoko Yamada, Kunimaro Furuta, Takahiro Kodama, Minoru Shigekawa, Hayato Hikita and 4 more

Open access · goldAbstract read
In one paragraph

Article in Hepatology communications, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 8 papers.

0numbers the graph read from it
0cells of the map it votes in
8citing papers in PubMed
0.6field-weighted citation impact, top 34% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

8 citing papers in PubMed, 13 citations in OpenAlex.

  1. Article
  2. Beta cells deficient forFrontiers in immunology · 2024
    Article
  3. Review
  4. Article
  5. Review
  6. Article
  7. Article
  8. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

14 authors at 1 institution in 1 country.

Takahiro SudaDepartment of Gastroenterology and Hepatology Osaka University Graduate School of Medicine Suita Japan.
Tomohide TatsumiDepartment of Gastroenterology and Hepatology Osaka University Graduate School of Medicine Suita Japan.
Akira NishioDepartment of Gastroenterology and Hepatology Osaka University Graduate School of Medicine Suita Japan.
Tadashi KegasawaDepartment of Gastroenterology and Hepatology Osaka University Graduate School of Medicine Suita Japan.
Teppei YoshiokaDepartment of Gastroenterology and Hepatology Osaka University Graduate School of Medicine Suita Japan.
Ryoko YamadaDepartment of Gastroenterology and Hepatology Osaka University Graduate School of Medicine Suita Japan.
Kunimaro FurutaDepartment of Gastroenterology and Hepatology Osaka University Graduate School of Medicine Suita Japan.
Takahiro KodamaDepartment of Gastroenterology and Hepatology Osaka University Graduate School of Medicine Suita Japan.
Minoru ShigekawaDepartment of Gastroenterology and Hepatology Osaka University Graduate School of Medicine Suita Japan.
Hayato HikitaDepartment of Gastroenterology and Hepatology Osaka University Graduate School of Medicine Suita Japan.
Ryotaro SakamoriDepartment of Gastroenterology and Hepatology Osaka University Graduate School of Medicine Suita Japan.
Takasuke FukuharaDepartment of Molecular Virology Research Institute for Microbial Diseases, Osaka University Suita Japan.
Yoshiharu MatsuuraDepartment of Molecular Virology Research Institute for Microbial Diseases, Osaka University Suita Japan.
Tetsuo TakeharaDepartment of Gastroenterology and Hepatology Osaka University Graduate School of Medicine Suita Japan.
Osaka University · JP

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Natural killer cells (NK cells) play an essential role in the immunological mechanism underlying chronic hepatitis C (CHC). Impairment of NK cell function facilitates persistent infection with hepatitis C virus (HCV) and hepatocellular carcinogenesis. However, the mechanism by which NK cell activity is suppressed in CHC is not completely understood. In this study, we focused on carcinoembryonic antigen-related cell-adhesion molecule 1 (CEACAM1). CEACAM1 is thought to suppress NK cell function. We examined the effect of CEACAM1 on NK cell function in CHC. We investigated the function of CEACAM1

Identifiers

PMID30288478
PMCPMC6167072
OpenAlexW2893665638

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.